newsfilter
← Latest News
PR Newswire·

CASI Pharmaceuticals Files Annual Report on Form 20-F for Fiscal Year 2022

BEIJING, April 26, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ:CASI) ("CASI" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapeutics